Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-22-032048

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 42.96M sh
Cash And Equivalents Q3 2022 · Sep 30, 2022 $6.95K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $27.99K
Total Liabilities Q3 2022 · Sep 30, 2022 $14.23K
Total Liabilities Q3 2022 · Dec 31, 2021 $239
Total Assets Q3 2022 · Sep 30, 2022 $16.94K
Total Assets Q3 2022 · Dec 31, 2021 $38.41K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$93.6K
Stockholders Equity Q3 2022 · Sep 30, 2021 $5.9K
Stockholders Equity Q3 2022 · Dec 31, 2020 $103.85K
Sga Expense Q3 2022 · Sep 30, 2021 $20.83K
Sga Expense Q3 2022 · Sep 30, 2021 $97.95K
Net Income Q3 2022 · Sep 30, 2021 −$20.83K
Net Income Q3 2022 · Sep 30, 2021 −$97.95K
Operating Income Q3 2022 · Sep 30, 2021 −$20.83K
Operating Income Q3 2022 · Sep 30, 2021 −$97.95K